Amarin Corp Plc (AMRN)

[HDGabor]

M-

What are your thoughts on Amarin launching it's own generic, versus giving up the US and focusing on Europe/ROW?

They have to focus on Europe/ROW since US gone ...

They could "save" something with authorized generic version but more likely - due to the type of the generic market / business model - they "have to" (mean makes sense) collaborate with a generic co. (e.g. Amarin will provide the drug and get a % of the revenue).

Ironically Hikma could be the most interested one since authorized generic could "nil" their 180-day exclusivity.

Or Teva ...

Teva may first begin selling its generic version of Vascepa in the United States on August 9, 2029, or earlier under certain customary circumstances, including commercial launch by another generic manufacturer under certain circumstances, in which event Teva would pay Amarin royalties on its generic version of Vascepa.

First: let's see the agenda next week ... LoOI or Opinion. (I expect LoOI.)

Best,
G